Mitogen-Activated Protein Kinase Kinase 2 (MAP2K2) Peptide

Product Graph
175.5€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Mitogen-Activated Protein Kinase Kinase 2 (MAP2K2) Peptide
category
Proteins and Peptides
provider
Abbexa
reference
abx617136
tested applications
P-ELISA

Description

Mitogen-Activated Protein Kinase Kinase 2 (MAP2K2) Peptide is a synthetic peptide. 

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Mitogen-Activated Protein Kinase Kinase 2 (MAP2K2)
Host
Synthetic
Recommended Dilution
BL (predicted): 0.5 mg/ml. Optimal dilutions/concentrations should be determined by the end user.
Conjugation
Unconjugated
Observed MW
Sequence Fragment: Internal region: C-DLKMLTNHTFIKRS
Size 1
100 µg
Form
Lyophilized Reconstitute in deionized water.
Tested Applications
P-ELISA
Buffer
Prior to lyophilization: Deionized water.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Gene ID
5605
NCBI Accession
NP_109587.1
Background
Protein MAP2K2
Note
This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

Related Products

EH14912

Human MAP2K2 (Dual specificity mitogen-activated protein kinase kinase 2) ELISA Kit

Ver Producto
FNab05113

MAP2K2 antibody

The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, mental retardation, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene.

Ver Producto
FNab10241

MAP2K2 antibody

Ver Producto